We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.

PURE
PURE Bioscience, Inc.
Other OTC
People also watch : HEB VICL QDEL SVA OPXA
1.00 -0.10 (-9.09%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • Max
1d
Prev Close 1.10
Open 1.03
Bid 0.00 x
Ask 0.00 x
52wk Range 0.65 - 1.55
Day's Range 1.00 - 1.10
Volume 93,102
Avg Vol (3m) 33,533
As of 3:59 PM EDT. Market closed.
  • Thomson Reuters StreetEvents 24 days ago

    Edited Transcript of PURE earnings conference call or presentation 9-Jun-16 8:30pm GMT

    Q3 2016 PURE Biosciences Inc Earnings Call

  • Capital Cube 2 months ago

    PURE Bioscience, Inc. :PURE-US: Earnings Analysis: Q2, 2016 By the Numbers : May 23, 2016

    Click here to see latest analysisPURE Bioscience, Inc. reports financial results for the quarter ended January 31, 2016.We analyze the earnings along side the following peers of PURE Bioscience, Inc. – Calgon Carbon Corporation, Ocean Bio-Chem, Inc., United-Guardian, Inc. and Ecolab Inc. (CCC-US, OBCI-US, UG-US and ECL-US) that have also reported for this period.HighlightsSummary numbers: […] (Read more...) The post PURE Bioscience, Inc. :PURE-US: Earnings Analysis: Q2, 2016 By the Numbers : May 23, 2016 appeared first on CapitalCube.

  • Capital Cube 4 months ago

    PURE Bioscience, Inc. :PURE-US: Earnings Analysis: Q2, 2016 By the Numbers

    Click here to see latest analysisPURE Bioscience, Inc. reports financial results for the quarter ended January 31, 2016.We analyze the earnings along side the following peers of PURE Bioscience, Inc. – Ecolab Inc. and Calgon Carbon Corporation (ECL-US and CCC-US) that have also reported for this period.HighlightsSummary numbers: Revenues of USD 0.18 million, Net Earnings […] (Read more...) The post PURE Bioscience, Inc. :PURE-US: Earnings Analysis: Q2, 2016 By the Numbers appeared first on CapitalCube.

  • Zacks Small Cap Research 4 months ago

    PURE: Update on Fiscal Second Quarter 2016 Financials

    By Grant Zeng, CFA OTC:PURE Revenue for the fiscal second quarter ended Jan 31, 2016 was $0.18 million, a 35.5% decline compared to $0.27 million for the same period of 2015. This decrease was mainly due ...

  • Thomson Reuters StreetEvents 6 months ago

    Edited Transcript of PURE earnings conference call or presentation 28-Oct-15 8:30pm GMT

    Full Year 2015 PURE Biosciences Inc Earnings Call

  • Capital Cube 7 months ago

    PURE Bioscience, Inc. Earnings Analysis: Q1, 2016 By the Numbers

    Click here to see latest analysisPURE Bioscience, Inc. reports financial results for the quarter ended October 31, 2015.PURE Bioscience, Inc. has an earnings momentum score of 57.10 and has a relative valuation rating of OVERVALUED. HighlightsSummary numbers: Revenues of USD 0.19 million, Net Earnings of USD -2.82 million, and Earnings per Share (EPS) of USD […] (Read more...) The post PURE Bioscience, Inc. Earnings Analysis: Q1, 2016 By the Numbers appeared first on CapitalCube.

  • Zacks Small Cap Research 9 months ago

    PURE Achieved 33% Increase in Total Revenue in Fiscal 2015

    This new financing greatly boosts the company’s balance sheet. Management has been working diligently to strengthen PURE’s balance sheet since they took office. In June, 2015, PURE resubmitted a Food Contact Notification (FCN) to the US FDA for Silver Dihydrogen Citrate (SDC) as an online reprocessing antimicrobial for raw poultry processing aid.

  • Zacks Small Cap Research 10 months ago

    PURE Resubmit FCN to FDA for SDC Use in Raw Poultry Processing and Produce Processing

    By Grant Zeng, CFA OTC:PURE In September and June 2015, PURE resubmitted a Food Contact Notification (FCN) to the US FDA for Silver Dihydrogen Citrate (SDC) as an online reprocessing (OLR) antimicrobial ...